To determine whether the impairment of cell growth following SOX2 elevation is exclusive to brain tumor cells, we used the same experimental approach described above for brain tumor cells to examine the response of prostate cancer cells to elevation of SOX2. Here, SOX2 is linked to prostate carcinoma.